Literature DB >> 10421818

Differences and similarities between chronic obstructive pulmonary disease and asthma.

P K Jeffery1.   

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are complex conditions with imprecise definitions, which make definitive morphological comparisons difficult. The airways in asthma are occluded by tenacious plugs of exudate and mucus, and there is fragility of airway surface epithelium, thickening of the reticular layer beneath the epithelial basal lamina (the last two not usually features of COPD), and bronchial vessel congestion and oedema. There is an increased inflammatory infiltrate comprising 'activated' lymphocytes and eosinophils with release of granular content in the latter, and enlargement of bronchial smooth muscle, particularly in medium-sized bronchi. CD4+ve lymphocytes predominate over CD8+ve cells and neutrophils are sparse. In contrast, three conditions contribute to COPD. In chronic bronchitis there is cough and mucous hypersecretion with enlargement of tracheobronchial submucosal glands and a disproportionate increase of mucous acini. CD8+ve lymphocytes predominate over CD4+ve cells and there are increased numbers of subepithelial macrophages and intra-epithelial neutrophils. Exacerbations of bronchitis are associated with a tissue eosinophilia, apparent absence of IL-5 protein but gene expression for IL-4 and IL-5 is present. In small or peripheral airways disease, there is inflammation of bronchioli and mucous metaplasia and hyperplasia, with increased intraluminal mucus, increased wall muscle, fibrosis, and airway stenoses (also referred to as chronic obstructive bronchiolitis). Respiratory bronchiolitis involving increased numbers of pigmented macrophages is a critically important early lesion. Increasingly severe peribronchiolitis includes infiltration of T lymphocytes in which the CD8+ subset again predominates. These inflammatory changes may predispose to the development of centrilobular emphysema and reduced FEV1 via the destruction of alveolar attachments. In emphysema there is abnormal, permanent enlargement of airspaces distal to the terminal bronchiolus (i.e. within the acinus) accompanied by destruction of alveolar walls and without obvious fibrosis. The severity of emphysema, rather than type, appears to be the most important determinant of chronic deterioration of airflow, and in this there may be significant loss of elastic recoil and microscopic emphysema prior to the observed macroscopic destruction of the acinus.

Entities:  

Mesh:

Year:  1999        PMID: 10421818

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  23 in total

1.  Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.

Authors:  K Amin; A Ekberg-Jansson; C-G Löfdahl; P Venge
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

2.  Determining the functional role of TRPC channels in primary cells.

Authors:  Su Li; Martin Gosling; Chris Poll
Journal:  Pflugers Arch       Date:  2005-08-03       Impact factor: 3.657

3.  Irreversible airway obstruction in asthma.

Authors:  Louis-Philippe Boulet
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

4.  Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages.

Authors:  S J Smith; P S Fenwick; A G Nicholson; F Kirschenbaum; T K Finney-Hayward; L S Higgins; M A Giembycz; P J Barnes; L E Donnelly
Journal:  Br J Pharmacol       Date:  2006-09-04       Impact factor: 8.739

5.  Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis.

Authors:  Bing Ma; Michael R Blackburn; Chun Geun Lee; Robert J Homer; Wei Liu; Richard A Flavell; Lynn Boyden; Richard P Lifton; Chun-Xiao Sun; Hays W Young; Jack A Elias
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

6.  Cathepsin K: a cysteine protease with unique kinin-degrading properties.

Authors:  Emmanuel Godat; Fabien Lecaille; Claire Desmazes; Sophie Duchêne; Enrico Weidauer; Paul Saftig; Dieter Brömme; Christophe Vandier; Gilles Lalmanach
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

7.  Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.

Authors:  S L Traves; S V Culpitt; R E K Russell; P J Barnes; L E Donnelly
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

8.  Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.

Authors:  Jean Bourbeau; Pota Christodoulopoulos; Francois Maltais; Yasuhiro Yamauchi; Ronald Olivenstein; Qutayba Hamid
Journal:  Thorax       Date:  2007-06-08       Impact factor: 9.139

Review 9.  Molecular pathogenesis of emphysema.

Authors:  Laimute Taraseviciene-Stewart; Norbert F Voelkel
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

10.  Keratinocyte growth factor (KGF) decreases ICAM-1 and VCAM-1 cell expression on bronchial epithelial cells.

Authors:  N Just; I Tillie-Leblond; B P H Guery; C Fourneau; A-B Tonnel; P Gosset
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.